Site web: https://maypharm.net/

Numéro de stand : H141

Catégorie

• Injectables: Toxines botuliniques
• Injectables: Produits de comblement
• Cosmeceutics - Produits anti-âge

Profil de l'entreprise

Since its founding in 2009, Maypharm has been dedicated to advancing the dermaceutical and medical aesthetics industry. Our vision is to enhance skin health through innovative and effective solutions. In just over a decade, we have become a leading force in Korea’s medical aesthetics market, guided by integrity, innovation, and consideration. Our high-quality products—including Skin Boosters, Dermal Fillers, and Botulinum Toxin—meet strict KFDA standards and carry global certifications such as CE and CPNP. At Maypharm, we value mutual growth, building strong global partnerships, and delivering superior products and services. In 2023, we reached a revenue milestone of 50 million USD, reflecting the trust of our customers and our ongoing commitment to excellence. Thank you for choosing Maypharm as your trusted partner in medical aesthetics.